Skip to main content
. Author manuscript; available in PMC: 2022 Sep 8.
Published in final edited form as: Am J Gastroenterol. 2021 Jan 1;116(1):162–170. doi: 10.14309/ajg.0000000000000766

Table 6:

Number of subjects with adverse events.

Adverse events 1 Hz 5 Hz 15 Hz
Fracture pelvis (withdrawn before randomization)
GI bleed secondary to NASIDS 1
Pneumonia 1
Skin discoloration 1
Kidney stone 1
Transient hand tingling and numbness 1
5th metatarsal fracture 1
Joint pains 1
Back pain, leg tingling & numbness 1